NEPH Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
5.6M
-6.6%
6.0M
+15.4%
5.2M
+10.2%
4.7M
-0.7%
4.8M
Cost of Revenue
2.3M
+17.3%
2.0M
-10.3%
2.2M
+12.8%
2.0M
+6.4%
1.8M
Gross Profit
3.3M
-18.4%
4.0M
+34.5%
3.0M
+8.4%
2.8M
-5.3%
2.9M
Operating Expenses
2.8M
-1.0%
2.8M
-2.9%
2.9M
+5.6%
2.7M
+5.5%
2.6M
R&D
331.0K
-9.6%
366.0K
+5.8%
346.0K
-12.4%
395.0K
+16.9%
338.0K
SG&A
2.4M
+0.3%
2.4M
-4.1%
2.5M
+8.9%
2.3M
+3.9%
2.2M
Operating Income
501.0K
-58.7%
1.2M
+1150.5%
97.0K
+438.9%
18.0K
-94.3%
314.0K
EBITDA
480.0K
-61.3%
1.2M
+900.8%
124.0K
+148.0%
50.0K
-82.3%
283.0K
Net Income
512.0K
-57.2%
1.2M
+755.0%
140.0K
+125.8%
62.0K
-81.6%
337.0K
EPS (Basic)
$0.05
-54.5%
$0.11
+1000.0%
$0.01
+0.0%
$0.01
-66.7%
$0.03
EPS (Diluted)
$0.05
-54.5%
$0.11
+1000.0%
$0.01
+0.0%
$0.01
-66.7%
$0.03
Shares (Diluted)
11.2M
+0.8%
11.1M
+1.1%
11.0M
-3.6%
11.4M
+3.3%
11.0M
Nephros (NEPH) — Financials